ME

MedPacto, Inc.

Develops biomarker-based precision therapies for oncology and other incurable diseases.

235980 | KO

Overview

Corporate Details

ISIN(s):
KR7235980000
LEI:
Country:
South Korea
Address:
서울특별시 서초구 명달로 92, 보림빌딩, 서초구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of innovative, biomarker-based therapeutics. Utilizing a genome-based drug discovery platform, the company aims to deliver precision medicine and personalized therapies. Its research and development pipeline focuses on creating first-in-class treatments for incurable diseases, with core areas in oncology, autoimmune disorders, metabolic diseases, and bone and joint diseases. A key scientific strategy includes modulating the tumor microenvironment to enhance the efficacy of anticancer drugs. The company is committed to transforming novel targets into therapeutic solutions for patients with unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-07-31 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 17.3 KB
2025-07-17 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-06-11 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험결과) (진행성 NSCLC를 대상으로 한 백토서팁과 더발루맙 병용요법의 제 1b/2a상,…
Korean 15.1 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 28.6 KB
2025-03-28 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 14.9 KB
2025-03-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 123.2 KB
2025-03-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 88.7 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 25.5 KB
2025-03-20 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 353.8 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 16.3 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 187.9 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.8 KB
2025-03-13 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 177.3 KB

Automate Your Workflow. Get a real-time feed of all MedPacto, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MedPacto, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MedPacto, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CARTA HOLDINGS, INC. Logo
Digital marketing firm offering ad platforms and integrated solutions to empower businesses.
Japan
3688
Celyad Oncology SA Logo
Clinical-stage biotech developing CAR T therapies for solid and blood cancers.
Belgium
CYAD
CENTAUR MEDIA PLC Logo
Provides business intelligence, learning, and consultancy for marketing & legal professionals.
United Kingdom
CAU
Century Therapeutics, Inc. Logo
Developing iPSC-derived, off-the-shelf cell therapies for cancer & autoimmune diseases.
United States of America
IPSC
Cereno Scientific AB Logo
Develops epigenetic therapies for rare cardiovascular and pulmonary diseases.
Sweden
CRNO
CERES INC. Logo
Develops online media platforms connecting consumers with advertisers through a rewards system.
Japan
3696
Certara, Inc. Logo
Accelerating new medicines with biosimulation software and services for pharma & biotech.
United States of America
CERT
CEVA INC Logo
Licensor of DSP, AI, wireless, and sensing IP for low-power, smart edge devices.
United States of America
CEVA
Chabiotech Co.,Ltd. Logo
Develops cell/gene therapies and offers CDMO, biobanking, and genomics services for rare diseases.
South Korea
085660
An Ad-Tech firm providing digital marketing, SEO, social media, and creative ad solutions.
South Korea
351870

Talk to a Data Expert

Have a question? We'll get back to you promptly.